Tau promotes oxidative stress-associated cycling neurons in S phase as a pro-survival mechanism: Possible implication for Alzheimer's disease.


Journal

Progress in neurobiology
ISSN: 1873-5118
Titre abrégé: Prog Neurobiol
Pays: England
ID NLM: 0370121

Informations de publication

Date de publication:
04 2023
Historique:
received: 23 05 2022
revised: 24 11 2022
accepted: 02 12 2022
medline: 28 3 2023
pubmed: 9 12 2022
entrez: 8 12 2022
Statut: ppublish

Résumé

Multiple lines of evidence have linked oxidative stress, tau pathology and neuronal cell cycle re-activation to Alzheimer's disease (AD). While a prevailing idea is that oxidative stress-induced neuronal cell cycle reactivation acts as an upstream trigger for pathological tau phosphorylation, others have identified tau as an inducer of cell cycle abnormalities in both mitotic and postmitotic conditions. In addition, nuclear hypophosphorylated tau has been identified as a key player in the DNA damage response to oxidative stress. Whether and to what extent these observations are causally linked remains unclear. Using immunofluorescence, fluorescence-activated nucleus sorting and single-nucleus sequencing, we report an oxidative stress-associated accumulation of nuclear hypophosphorylated tau in a subpopulation of cycling neurons confined in S phase in AD brains, near amyloid plaques. Tau downregulation in murine neurons revealed an essential role for tau to promote cell cycle progression to S phase and prevent apoptosis in response to oxidative stress. Our results suggest that tau holds oxidative stress-associated cycling neurons in S phase to escape cell death. Together, this study proposes a tau-dependent protective effect of neuronal cell cycle reactivation in AD brains and challenges the current view that the neuronal cell cycle is an early mediator of tau pathology.

Identifiants

pubmed: 36481386
pii: S0301-0082(22)00172-1
doi: 10.1016/j.pneurobio.2022.102386
pii:
doi:

Substances chimiques

tau Proteins 0
Amyloid beta-Peptides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102386

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interests The authors declare that they have no competing interests.

Auteurs

Marine Denechaud (M)

University of Lille, Inserm, CHU Lille, CNRS, LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France. Electronic address: marine.denechaud@inserm.fr.

Sarah Geurs (S)

Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium; Department of Human Genetics, University of Leuven (KU Leuven), 3000 Leuven, Belgium. Electronic address: sarah.geurs@kuleuven.be.

Thomas Comptdaer (T)

University of Lille, Inserm, CHU Lille, CNRS, LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France. Electronic address: thomas.comptdaer@inserm.fr.

Séverine Bégard (S)

University of Lille, Inserm, CHU Lille, CNRS, LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France. Electronic address: severine.begard@inserm.fr.

Alejandro Garcia-Núñez (A)

University of Lille, Inserm, CHU Lille, CNRS, LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France. Electronic address: hpayns@gmail.com.

Louis-Adrien Pechereau (LA)

University of Lille, Inserm, CHU Lille, CNRS, LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France. Electronic address: louisadrien.pechereau@gmail.com.

Thomas Bouillet (T)

University of Lille, Inserm, CHU Lille, CNRS, LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France. Electronic address: thomas.bouillet@inserm.fr.

Yannick Vermeiren (Y)

Laboratory of Neurochemistry and Behavior, and Biobank, Institute Born-Bunge, University of Antwerp, Universiteitsplein 1, BE-2610 Antwerpen, Belgium. Electronic address: yannick.vermeiren@uantwerpen.be.

Peter P De Deyn (PP)

Laboratory of Neurochemistry and Behavior, and Biobank, Institute Born-Bunge, University of Antwerp, Universiteitsplein 1, BE-2610 Antwerpen, Belgium; Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, eindendreef 1, 2020 Antwerpen, Belgium. Electronic address: peter.dedeyn@uantwerpen.be.

Romain Perbet (R)

University of Lille, Inserm, CHU Lille, CNRS, LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France. Electronic address: RPERBET@mgh.harvard.edu.

Vincent Deramecourt (V)

University of Lille, Inserm, CHU Lille, CNRS, LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France; Department of Pathological Anatomy, University of Lille, CHU Lille, Lille, France. Electronic address: Vincent.DERAMECOURT@CHRU-LILLE.FR.

Claude-Alain Maurage (CA)

University of Lille, Inserm, CHU Lille, CNRS, LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France; Department of Pathological Anatomy, University of Lille, CHU Lille, Lille, France. Electronic address: Claude-Alain.MAURAGE@CHRU-LILLE.FR.

Michiel Vanderhaegen (M)

Department of Human Genetics, University of Leuven (KU Leuven), 3000 Leuven, Belgium. Electronic address: michiel.vanderhaeghen@kuleuven.be.

Sebastiaan Vanuytven (S)

Department of Human Genetics, University of Leuven (KU Leuven), 3000 Leuven, Belgium. Electronic address: sebastiaan.vanuytven@kuleuven.be.

Bruno Lefebvre (B)

University of Lille, Inserm, CHU Lille, CNRS, LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France. Electronic address: bruno.lefebvre@inserm.fr.

Elke Bogaert (E)

Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium. Electronic address: Elke.Bogaert@UGent.be.

Nicole Déglon (N)

Lausanne University Hospital (CHUV) and University of Lausanne, Neuroscience Research Center (CRN), Laboratory of Cellular and Molecular Neurotherapies, 1011 Lausanne, Switzerland. Electronic address: nicole.deglon@chuv.ch.

Thierry Voet (T)

Department of Human Genetics, University of Leuven (KU Leuven), 3000 Leuven, Belgium; KU Leuven, Institute for Single Cell Omics (LISCO), KU Leuven, 3000 Leuven, Belgium. Electronic address: thierry.voet@kuleuven.be.

Morvane Colin (M)

University of Lille, Inserm, CHU Lille, CNRS, LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France. Electronic address: morvane.colin@inserm.fr.

Luc Buée (L)

University of Lille, Inserm, CHU Lille, CNRS, LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France. Electronic address: luc.buee@inserm.fr.

Bart Dermaut (B)

Center for Medical Genetics, Ghent University Hospital, 9000 Ghent, Belgium; Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium. Electronic address: bart.dermaut@ugent.be.

Marie-Christine Galas (MC)

University of Lille, Inserm, CHU Lille, CNRS, LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France. Electronic address: marie-christine.galas@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH